Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral naloxone for methadone-induced constipation
IRCT20190207042648N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naloxone in drug-induced constipation and opioid-induced constipation (OIC) (4 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Constipation score, Withdrawal scoring and 1 more. Started Jul 2020; status: completed.
02
Drugs
naloxone
03
Conditions
drug-induced constipationopioid-induced constipation (OIC)
Beyond the preview
Go deeper on IRCT20190207042648N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190207042648N2.